title: New frontiers and clinical applications for botulinum neuromodulators.
authors.affiliation: Department of Dermatology, UC Davis Medical Center, Sacramento, California, Dermatology Service, Sacramento VA Medical Center, Mather, California, Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, New York Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada Private Practice, Niagara Falls, Ontario, Canada.
authors.forename: Jared
authors.initials: J
authors.lastname: Jagdeo
authors.forename: Alastair
authors.initials: A
authors.lastname: Carruthers
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Smith
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D009498:Neurotoxins / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy
chemical_list: D065087:Acetylcholine Release Inhibitors; D009498:Neurotoxins; D019274:Botulinum Toxins, Type A